R
Robert J. Siegel
Researcher at Cedars-Sinai Medical Center
Publications - 506
Citations - 25581
Robert J. Siegel is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Mitral regurgitation & Mitral valve. The author has an hindex of 75, co-authored 463 publications receiving 22687 citations. Previous affiliations of Robert J. Siegel include Northern General Hospital & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.
TL;DR: For severe rheumatic MS, medical therapy is ineffective and definitive therapy entails PMBC in patients with suitable morphological mitral valve (MV) characteristics, or surgery.
Journal ArticleDOI
Natriuretic Peptides for Risk Stratification of Patients With Valvular Aortic Stenosis
TL;DR: In this article, the authors proposed a risk stratification of patients with aortic stenosis (AS), especially in high-risk asymptomatic patients, patients with atypical symptoms, and those with symptoms but with a high surgical or procedural risk.
Journal ArticleDOI
Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: The Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial
Tarun Chakravarty,Timothy D. Henry,Michelle M. Kittleson,Joao A.C. Lima,Robert J. Siegel,Leandro Slipczuk,Janice M. Pogoda,Rachel R Smith,Konstantinos Malliaras,Linda Marbán,Deborah D. Ascheim,Eduardo Marbán,Raj Makkar +12 more
TL;DR: Global intracoronary infusion of allogeneic CDCs is safe and feasible in patients with heart failure and reduced ejection fraction and needs to be tested in larger randomized trials.
Journal ArticleDOI
Postprocedural Changes of Tricuspid Regurgitation After MitraClip Therapy for Mitral Regurgitation.
Kentaro Toyama,Kengo Ayabe,Saibal Kar,Shunsuke Kubo,Toshinori Minamishima,Florian Rader,Takahiro Shiota,Toshihiko Nishioka,Robert J. Siegel +8 more
TL;DR: TR regression was observed in 23% of the patients after the successful MitraClip procedures, and favorable echocardiographic parameter changes were detected in this group.
Journal ArticleDOI
Arterial thrombus dissolution in vivo using a transducer-tipped, high-frequency ultrasound catheter and local low-dose urokinase delivery.
TL;DR: Catheter-delivered high-frequency ultrasound and local low-dose urokinase infusion is efficacious for the treatment of acute thrombotic occlusions as evaluated by angiography, angioscopy, and histopathology.